2013
DOI: 10.1016/j.jns.2013.07.2448
|View full text |Cite
|
Sign up to set email alerts
|

Levodopa-responsive parkinsonism and autonomic (small fiber) dysfunction in patients with Wilson'/INS;s disease (WD)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Dopaminergic treatment (levodopa, ropinirole, apomorphine) was administrated to a few WD cases and in case series reports. [40][41][42][43][44][45] A majority of reports showed no effect of dopaminergic drugs. However, due to the proven dopaminergic neurotransmission failure in patients with WD and the low prevalence of adverse reactions to dopaminergic treatment, we suggest that dopaminergic compounds should be tried in patients with WD to treat dystonia and parkinsonism.…”
Section: [32]mentioning
confidence: 99%
“…Dopaminergic treatment (levodopa, ropinirole, apomorphine) was administrated to a few WD cases and in case series reports. [40][41][42][43][44][45] A majority of reports showed no effect of dopaminergic drugs. However, due to the proven dopaminergic neurotransmission failure in patients with WD and the low prevalence of adverse reactions to dopaminergic treatment, we suggest that dopaminergic compounds should be tried in patients with WD to treat dystonia and parkinsonism.…”
Section: [32]mentioning
confidence: 99%